23 March 2023
News
30 September 2022
Hemarina helps to heal injuries in reconstructive surgery with HEMO2life® oxygen carrier
During his visit to France’s Percy Army Training Hospital on 28 April 2022, The French President met several soldiers who
5 May 2022
Amrita Institute of Medical Sciences (AIMS) in Kochi, India, Becomes the First Hospital in the World to Carry Out Bilateral Upper Limb Transplant using HEMO2life®
HEMO2life® oxygen carrier medical device derived from Arenicola marina lugworm facilitating grafts preservation without delayed graft function opens up new
9 November 2021
HEMARINA awarded the Start-Up of the Year Prize during the Western Region EY Entrepreneur of the Year 2018 ceremony
Morlaix (France), October 19, 2018 – EY has awarded the National Start-Up of the Year Prize to Hemarina and its
1 April 2021
HEMARINA AND DELPHARM TEAM UP TO MANUFACTURE HEMO2life®
Morlaix and Boulogne-Billancourt (France), 29 November 2018 Hemarina and Delpharm today announced the signature of a partnership involving the manufacture
1 April 2021
LUGWORM BLOOD, COMING SOON TO A PHARMACY NEAR YOU
Hakai Magazine (Canada) – 31/01/2019https://www.hakaimagazine.com/news/lugworm-blood-coming-soon-to-a-pharmacy-near-you/
1 April 2021
BIOMIMICRY FOR HEALTH
Biomimicry for healthLe Particulier Santé Nature has had millions of years to evolve, adapt and survive. Today, it is an
31 March 2021
CORONAVIRUS: HEMARINA’S MOLECULE CAN SAVE LIVES BY REPLACING LIFE-SUPPORT VENTILATORS FOR OXYGENATING PATIENTS WITH COVID-19
Morlaix, Brittany (France), March 23rd 2020 – Day 6 of confinement – Hemarina, a French biotech company, is ready to
31 March 2021
Categories
- News (7)
- PODCAST (1)
- Press releases (9)
- Uncategorized (9)
